LSD was marketed as a medicine under the name Delysid for over 10 years mid-century but only afterward did it gain a schedule 1 classification after it was declared to have no medical uses.
Edit: Replying with a 45 year-old study with extremely low scientific merit is silly especially on HN. I was asking specifically for references to the reproducibility op mentioned.
For the terminally ill: https://www.independent.co.uk/news/people/professor-david-nu...
Treating depression: https://www.ft.com/content/2c4121de-c5d6-11e5-808f-8231cd716... https://www.theguardian.com/science/2015/mar/05/psychedelic-...
Microdosing: https://psyarxiv.com/gk4jd/
In NYC, for example, it is now perfectly legal to get a heavy dosage of ketamine administered by Columbia University doctors (see https://www.columbiadoctors.org/specialties/psychiatry-psych...)
> A typical case would be 8-12 infusions over 4-6 weeks.
That's $7,800 for a month of treatment. That's a lot of money when considering that ketamine is not a cure and the patient will need future treatments.
I'm taking 250mg sublingual every day and paying ~$3000/year. Most of the cost is taxis, planes, and shipping because I'm out of state and have to fly in to see my doctor. If I lived in Maryland the cost would be much lower.
Also, if infusion clinic docs weren't bankrupting patients by picking the most expensive (read: lucrative) ROA the cost would be much cheaper.
Do you happen to know of other documents in a vein similar to the LSD one you linked? Pharmacology is one of many bizarre topics I endeavor to understand in my free time (this weird thing called "programming" also happens to be one).
[1]: https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.1620
I’ll make the observation that if recreational drugs weren’t doing interesting things to the brain, people wouldn’t use them, but psychedelics in particular do near miraculous seeming things with reproducibility that prescription drug companies would kill for in a candidate for a commercial drug.